Deerfield Management Company as of June 30, 2019
Portfolio Holdings for Deerfield Management Company
Deerfield Management Company holds 97 positions in its portfolio as reported in the June 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Horizon Therapeutics | 5.6 | $156M | 6.5M | 24.06 | |
| Horizon Pharma Plc convertible security | 5.4 | $151M | 136M | 1.11 | |
| Mylan Nv | 5.1 | $142M | 7.5M | 19.04 | |
| Orchard Therapeutics Plc ads | 4.5 | $125M | 8.9M | 13.99 | |
| Nevro Corp note 1.750% 6/0 | 4.3 | $120M | 116M | 1.04 | |
| Homology Medicines | 4.0 | $113M | 5.8M | 19.57 | |
| Aerie Pharmaceuticals | 3.2 | $90M | 3.0M | 29.55 | |
| Intersect Ent | 2.5 | $71M | 3.1M | 22.76 | |
| Immunomedics | 2.5 | $69M | 5.0M | 13.87 | |
| Acceleron Pharma | 1.9 | $54M | 1.3M | 41.08 | |
| Brookdale Senior Living (BKD) | 1.9 | $52M | 7.2M | 7.21 | |
| Insulet Corp note 1.375%11/1 | 1.9 | $52M | 37M | 1.42 | |
| Intercept Pharmas conv | 1.9 | $51M | 58M | 0.89 | |
| Ra Pharmaceuticals | 1.9 | $52M | 1.7M | 30.07 | |
| Myokardia | 1.8 | $50M | 997k | 50.14 | |
| Sarepta Therapeutics (SRPT) | 1.7 | $47M | 309k | 151.95 | |
| Diplomat Pharmacy | 1.5 | $43M | 7.0M | 6.09 | |
| Argenx Se (ARGX) | 1.4 | $40M | 281k | 141.58 | |
| Vericel (VCEL) | 1.4 | $39M | 2.1M | 18.89 | |
| Mallinckrodt Pub | 1.4 | $38M | 4.2M | 9.18 | |
| Coherus Biosciences (CHRS) | 1.3 | $37M | 1.7M | 22.10 | |
| Blueprint Medicines (BPMC) | 1.3 | $37M | 391k | 94.33 | |
| Fate Therapeutics (FATE) | 1.2 | $35M | 1.7M | 20.30 | |
| Alector (ALEC) | 1.2 | $33M | 1.7M | 19.00 | |
| Select Medical Holdings Corporation (SEM) | 1.2 | $32M | 2.0M | 15.87 | |
| Dexcom Inc dbcv 0.750% 5/1 | 1.1 | $32M | 20M | 1.60 | |
| Kempharm Inc note 5.500% 2/0 | 1.1 | $31M | 65M | 0.48 | |
| Anaptysbio Inc Common (ANAB) | 1.1 | $31M | 541k | 56.42 | |
| Sientra | 1.0 | $29M | 4.7M | 6.16 | |
| Editas Medicine (EDIT) | 1.0 | $29M | 1.2M | 24.74 | |
| Natera (NTRA) | 1.0 | $28M | 1.0M | 27.58 | |
| Ptc Therapeutics Inc conv bd us | 1.0 | $28M | 25M | 1.11 | |
| Mirati Therapeutics | 1.0 | $27M | 265k | 103.00 | |
| Xeris Pharmaceuticals | 1.0 | $27M | 2.4M | 11.44 | |
| Kalvista Pharmaceuticals (KALV) | 1.0 | $27M | 1.2M | 22.15 | |
| eHealth (EHTH) | 1.0 | $27M | 311k | 86.10 | |
| Dbv Technologies S A (DBVT) | 0.9 | $26M | 3.2M | 8.22 | |
| Exact Sciences Corp convertible/ | 0.9 | $26M | 15M | 1.72 | |
| Dfb Healthcare Acquistion Co unit 01/30/2023 | 0.9 | $26M | 2.5M | 10.37 | |
| STAAR Surgical Company (STAA) | 0.9 | $26M | 877k | 29.38 | |
| Nevro (NVRO) | 0.9 | $25M | 386k | 64.83 | |
| Silk Road Medical Inc Common (SILK) | 0.9 | $24M | 499k | 48.46 | |
| BioCryst Pharmaceuticals (BCRX) | 0.9 | $24M | 6.3M | 3.79 | |
| Invitae (NVTAQ) | 0.8 | $23M | 995k | 23.50 | |
| Molina Healthcare (MOH) | 0.8 | $22M | 150k | 143.14 | |
| Ptc Therapeutics I (PTCT) | 0.8 | $21M | 471k | 45.00 | |
| Arvinas Ord (ARVN) | 0.7 | $20M | 921k | 21.99 | |
| Wright Medical Group Nv 2.25 20211115 | 0.7 | $20M | 14M | 1.48 | |
| Addus Homecare Corp (ADUS) | 0.7 | $19M | 253k | 74.95 | |
| Reata Pharmaceuticals Inc Cl A | 0.7 | $19M | 197k | 94.35 | |
| Audentes Therapeutics | 0.7 | $19M | 494k | 37.86 | |
| Humana (HUM) | 0.6 | $18M | 67k | 265.30 | |
| Kiniksa Pharmaceuticals (KNSA) | 0.6 | $18M | 1.3M | 13.54 | |
| Shockwave Med (SWAV) | 0.6 | $18M | 312k | 57.09 | |
| Axogen (AXGN) | 0.6 | $18M | 891k | 19.80 | |
| Wave Life Sciences (WVE) | 0.6 | $18M | 669k | 26.09 | |
| Rocket Pharmaceuticals (RCKT) | 0.6 | $17M | 1.1M | 15.00 | |
| Centene Corporation (CNC) | 0.6 | $16M | 303k | 52.44 | |
| Clovis Oncology Inc note 2.500% 9/1 | 0.6 | $16M | 18M | 0.88 | |
| Anthem (ELV) | 0.5 | $15M | 53k | 282.21 | |
| Morphosys (MOR) | 0.5 | $15M | 600k | 24.14 | |
| Deciphera Pharmaceuticals (DCPH) | 0.5 | $14M | 608k | 22.55 | |
| Rhythm Pharmaceuticals (RYTM) | 0.5 | $14M | 624k | 22.00 | |
| Galapagos Nv- (GLPG) | 0.5 | $13M | 101k | 128.93 | |
| Global Blood Therapeutics In | 0.4 | $12M | 235k | 52.60 | |
| Athenex | 0.4 | $12M | 622k | 19.80 | |
| Syros Pharmaceuticals | 0.4 | $12M | 1.3M | 9.26 | |
| Turning Point Therapeutics I | 0.4 | $12M | 288k | 40.70 | |
| Phasebio Pharmaceuticals (PHASQ) | 0.4 | $11M | 851k | 13.12 | |
| Synlogic | 0.4 | $10M | 1.1M | 9.10 | |
| Tandem Diabetes Care (TNDM) | 0.3 | $9.8M | 153k | 64.52 | |
| Ardelyx (ARDX) | 0.3 | $9.3M | 3.5M | 2.69 | |
| Inspire Med Sys (INSP) | 0.3 | $9.2M | 151k | 60.65 | |
| Chewy Inc cl a (CHWY) | 0.3 | $9.1M | 261k | 35.00 | |
| Aclaris Therapeutics (ACRS) | 0.3 | $8.7M | 4.0M | 2.19 | |
| X4 Pharmaceuticals (XFOR) | 0.3 | $8.5M | 565k | 15.00 | |
| Flamel Technologies Sa (AVDL) | 0.3 | $7.9M | 2.7M | 2.89 | |
| Bridgebio Pharma (BBIO) | 0.3 | $7.8M | 290k | 26.97 | |
| Sorrento Therapeutics (SRNEQ) | 0.2 | $5.6M | 2.1M | 2.67 | |
| Alimera Sciences | 0.2 | $5.4M | 6.1M | 0.89 | |
| Teligent Inc New bond | 0.2 | $5.1M | 9.6M | 0.53 | |
| Ideaya Biosciences (IDYA) | 0.1 | $4.2M | 425k | 9.96 | |
| BioDelivery Sciences International | 0.1 | $3.8M | 816k | 4.65 | |
| Medicines Company | 0.1 | $3.6M | 100k | 36.47 | |
| Harpoon Therapeutics | 0.1 | $3.7M | 285k | 13.00 | |
| Aeglea Biotherapeutics | 0.1 | $3.4M | 500k | 6.85 | |
| Itamar Med | 0.1 | $3.5M | 314k | 11.00 | |
| Adaptive Biotechnologies Cor (ADPT) | 0.1 | $3.4M | 70k | 48.30 | |
| Pfenex | 0.1 | $2.7M | 394k | 6.74 | |
| Constellation Pharmceticls I | 0.1 | $2.3M | 184k | 12.28 | |
| Neuronetics (STIM) | 0.1 | $2.0M | 159k | 12.51 | |
| Alpine Immune Sciences (ALPN) | 0.1 | $1.8M | 416k | 4.21 | |
| Eyenovia Inc equity (EYEN) | 0.1 | $1.3M | 300k | 4.30 | |
| Orthopediatrics Corp. (KIDS) | 0.0 | $1.2M | 32k | 39.00 | |
| Menlo Therapeutics | 0.0 | $1.2M | 199k | 5.99 | |
| Proteon Therapeutics | 0.0 | $515k | 1.2M | 0.42 | |
| Neos Therapeutics | 0.0 | $414k | 321k | 1.29 |
